116 related articles for article (PubMed ID: 7488434)
1. High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: results of a phase II study.
Jäger E; Klein O; Wchter B; Müller B; Braun U; Knuth A
Eur J Cancer; 1995 Sep; 31A(10):1717. PubMed ID: 7488434
[No Abstract] [Full Text] [Related]
2. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.
Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ
Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765
[TBL] [Abstract][Full Text] [Related]
3. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer.
Haas NB; Schilder RJ; Nash S; Weiner LM; Catalano RC; Ozols RF; O'Dwyer PJ
Invest New Drugs; 1995; 13(3):229-33. PubMed ID: 8729951
[TBL] [Abstract][Full Text] [Related]
5. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
[No Abstract] [Full Text] [Related]
8. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
Arkenau HT; Rettig K; Porschen R
Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
[TBL] [Abstract][Full Text] [Related]
10. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial.
Breul J; Jakse G; Forster G; Lampel A; Rohani A; Hartung R
Eur Urol; 1997; 32(3):280-3. PubMed ID: 9358213
[TBL] [Abstract][Full Text] [Related]
15. [Results of treatment with 5-fluorouracil and folinic acid in patients with carcinoma of the large intestine].
Nastasi G; Sala L; Romano AM; Nucera D; Anselmetti L; Castoldi O; Crema F; Pasotti D
Medicina (Firenze); 1988; 8(2):175-8. PubMed ID: 2852292
[No Abstract] [Full Text] [Related]
16. Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.
Martoni A; Cricca A; Guaraldi M; Covizzi M; Farris A; Pannuti F
Anticancer Res; 1992; 12(3):607-12. PubMed ID: 1622115
[TBL] [Abstract][Full Text] [Related]
17. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients.
Bécouarn Y; Gamelin E; Coudert B; Négrier S; Pierga JY; Raoul JL; Provençal J; Rixe O; Krisch C; Germa C; Bekradda M; Mignard D; Mousseau M
J Clin Oncol; 2001 Nov; 19(22):4195-201. PubMed ID: 11709562
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of colorectal cancer.
Kemeny N; Saltz L; Cohen A
Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.
Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Jasmin C; Maral R; Mathé G
Cancer Treat Rep; 1982 Oct; 66(10):1803-7. PubMed ID: 6982099
[No Abstract] [Full Text] [Related]
20. [Possible effect of administration methods on pharmacological action. Study of cytostatic therapy in advanced cancer].
Larsson PA; Carlsson G; Gustavsson B; Glimelius B; Graf W
Lakartidningen; 1995 Dec; 92(50):4793-6. PubMed ID: 8538293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
